In a Medscape Gastroenterology article covering Digestive Disease Week (DDW) 2018, William Balistreri, MD, reported on the studies presented that addressed reliable, cost-effective celiac disease detection. One of the studies highlighted in the article, Forgoing the Duodenal Biopsy for Celiac Disease Diagnosis Among Adults in the United States: Results of a National Survey, analyzed data…

Previous studies have found celiac disease to be associated with several neurological complications. In a new study, researchers reviewed the available literature to determine the prevalence of epilepsy in patients with celiac disease or gluten sensitivity, and vice versa. For the purposes of this study, the researchers defined “gluten sensitivity” as patients with positive celiac-specific…

At the 2018 ACG Annual Scientific Meeting, Columbia University Medical Center researchers – including Celiac Disease Foundation Medical Advisory Board member Peter Green and Research Committee member Benjamin Lebwohl – presented results from a new study on detecting gluten in restaurant foods. The researchers found 32% of restaurant foods labeled “gluten-free” contained detectable amounts of…

On September 27th, 2018, ImmusanT, Inc., announced that the first patient has been dosed in its Phase 2 clinical trial, RESET CeD. The RESET CeD trial will test the safety and efficacy of Nexvax2®, a therapeutic vaccine for the treatment of celiac disease patients who carry the immune recognition genes for HLA-DQ2.5 (approximately 90% of celiac…

Previous studies have found celiac disease to be associated with several conditions affecting pregnancy and female reproductive outcomes. In a new population-based study, researchers sought to determine how celiac disease affects pregnancy outcomes, both before and after celiac disease diagnosis. Using data from Danish national registries, researchers compared pregnancy outcomes in women with celiac disease…